- Home
- HOTH vs CHNR Comparison
HOTH vs CHNR Comparison
Compare HOTH & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOTH
- CHNR
- Stock Information
- Founded
- HOTH 2017
- CHNR N/A
- Country
- HOTH United States
- CHNR Hong Kong
- Employees
- HOTH N/A
- CHNR N/A
- Industry
- HOTH Biotechnology: Pharmaceutical Preparations
- CHNR Precious Metals
- Sector
- HOTH Health Care
- CHNR Basic Materials
- Exchange
- HOTH Nasdaq
- CHNR Nasdaq
- Market Cap
- HOTH 7.6M
- CHNR 6.4M
- IPO Year
- HOTH 2019
- CHNR 1995
- Fundamental
- Price
- HOTH $0.82
- CHNR $0.66
- Analyst Decision
- HOTH Strong Buy
- CHNR
- Analyst Count
- HOTH 4
- CHNR 0
- Target Price
- HOTH $4.75
- CHNR N/A
- AVG Volume (30 Days)
- HOTH 996.3K
- CHNR 27.1K
- Earning Date
- HOTH 11-12-2024
- CHNR 01-01-0001
- Dividend Yield
- HOTH N/A
- CHNR N/A
- EPS Growth
- HOTH N/A
- CHNR N/A
- EPS
- HOTH N/A
- CHNR N/A
- Revenue
- HOTH N/A
- CHNR N/A
- Revenue This Year
- HOTH N/A
- CHNR N/A
- Revenue Next Year
- HOTH N/A
- CHNR N/A
- P/E Ratio
- HOTH N/A
- CHNR N/A
- Revenue Growth
- HOTH N/A
- CHNR N/A
- 52 Week Low
- HOTH $0.58
- CHNR $0.55
- 52 Week High
- HOTH $1.73
- CHNR $8.85
- Technical
- Relative Strength Index (RSI)
- HOTH 42.93
- CHNR 46.40
- Support Level
- HOTH $0.83
- CHNR $0.62
- Resistance Level
- HOTH $0.90
- CHNR $0.73
- Average True Range (ATR)
- HOTH 0.09
- CHNR 0.06
- MACD
- HOTH -0.01
- CHNR -0.00
- Stochastic Oscillator
- HOTH 10.18
- CHNR 49.94
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.
About CHNR China Natural Resources Inc.
China Natural Resources Inc is an investment holding company. It principally engaged in the exploration and mining and wastewater treatment businesses in the People's Republic of China. The company has two operating segments: (i) Wastewater treatment segment, which consists of sales of assembled equipment, provision of construction service, and participation in PPP projects as an operator (ii) Exploration and mining segment, which consists of the exploration of lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and the trading of copper ores products. It earns the majority of its revenue from the Wastewater treatment segment.